Recent advances in the development of EGFR/Src, Src/Abl, EGFR/VEGFR2, EGFR/c-Met, STAT-3/c-Src, VGERF/FAK and EGFR/HER dual-targeted kinase inhibitors ,2026
Novel Indole Derivatives as SRC/EGFR Inhibitors: Synthesis, Biological Evaluation, and In Silico Analysis ,2026
Investigating the Activity of Indole-2-on Derivative Src kinase inhibitors against Chronic Myeloid Leukemia Cells ,2023
Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors ,2024
Determination of Novel SARS-CoV-2 Inhibitors by Combination of Machine Learning and Molecular Modeling Methods ,2024
Reports
Design and Synthesis of Novel Indole Derivatives as Tyrosine Kinase Inhibitors - ÖLGEN SÜREYYA, KARATAŞ BRISTOW HACER
In silico investigation of membrane transporter activity of indole
derivatives as SRC tyrosine kinase inhibitors - Takač Milena Jadrijević-Mladar, ÖLGEN SÜREYYA, Takac Tin
DETERMINATION OF POTENTIAL CANDIDATES OF NOVEL UREA AND SULFONAMIDE DERIVATIVES OF ISATIN SCHIFF BASES AS RECEPTOR TYROSINE KINASE INHIBITOR BY MOLECULAR DOCKING STUDIES. - DEMİREL URAL UFUK, ÖLGEN SÜREYYA
DESIGN, SYNTHESIS, ADME AND MOLECULAR DOCKING STUDIES OF NOVEL UREA AND SULFONAMIDE DERIVATIVES OF ISATINE AS POTENTIAL ANTICANCER AGENTS - DEMİREL URAL UFUK, Karaman Fatma Ecem, TANOL MEHMET, ÖZDEN SİBEL, GÖKER ALİ HAKAN, ÖLGEN SÜREYYA
Cytotoxic and Antiproliferative Activity of N- (4-Chlorophenyl) -1 H-Indole-2-Carboxamide on Prostate and Osteosarcoma Cell Lines. - ŞENTÜRK AHMET MESUT,ÖLGEN SÜREYYA,ORDUERİ NAZLI ECE
Books
Drug Repurposing in Cancer Therapy: Approaches and Applications – Elsevier
Patrick Medisinal Kimya – Nobel
Kalitatif ve Kantitatif İlaç Analizleri – Ankara Üniversitesi
Kalitatif ve Kantitatif İlaç Analizleri I – Ankara Üniversitesi
